Clinical Trial Update: Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

ClinicalTrials.gov indicates a completed Phase 1/2 study evaluating cilengitide with temozolomide and radiation for newly diagnosed glioblastoma multiforme, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma
• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Temozolomide (Temozolomide)
• cilengitide (cilengitide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-02-25